Clinical Trial Detail

NCT ID NCT02815995
Title Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

hemangioma

leiomyosarcoma

synovial sarcoma

lipoma

osteosarcoma

angiosarcoma

sarcoma

Therapies

Durvalumab + Tremelimumab

Age Groups: senior adult child

No variant requirements are available.